======= ALDH1A3 ======= == Gene Information == * **Official Symbol**: ALDH1A3 * **Official Name**: aldehyde dehydrogenase 1 family member A3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=220|220]] * **UniProt**: [[https://www.uniprot.org/uniprot/P47895|P47895]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ALDH1A3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ALDH1A3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600463|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an aldehyde dehydrogenase enzyme that uses retinal as a substrate. Mutations in this gene have been associated with microphthalmia, isolated 8, and expression changes have also been detected in tumor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]. * **UniProt Summary**: NAD-dependent aldehyde dehydrogenase that catalyzes the formation of retinoic acid (PubMed:27759097). Has high activity with all-trans retinal, and has much lower in vitro activity with acetaldehyde (PubMed:27759097). Required for the biosynthesis of normal levels of retinoic acid in the embryonic ocular and nasal regions; retinoic acid is required for normal embryonic development of the eye and the nasal region (By similarity). {ECO:0000250|UniProtKB:Q9JHW9, ECO:0000269|PubMed:27759097}. |Aldedh| |nucleus accumbens development| |olfactory pit development| |Harderian gland development| |aldehyde dehydrogenase [NAD(P)+] activity| |righting reflex| |thyroid hormone binding| |retinoic acid biosynthetic process| |retinal dehydrogenase activity| |optic cup morphogenesis involved in camera-type eye development| |diterpenoid biosynthetic process| |embryonic camera-type eye formation| |aldehyde dehydrogenase (NAD) activity| |retinal metabolic process| |terpenoid biosynthetic process| |nose development| |NAD+ binding| |striatum development| |reflex| |subpallium development| |embryonic camera-type eye morphogenesis| |isoprenoid biosynthetic process| |retinoic acid metabolic process| |embryonic eye morphogenesis| |embryonic camera-type eye development| |retinol metabolic process| |face development| |neuromuscular process controlling balance| |cellular aldehyde metabolic process| |neural nucleus development| |primary alcohol metabolic process| |protein homotetramerization| |inner ear morphogenesis| |retinoid metabolic process| |neuromuscular process| |limbic system development| |diterpenoid metabolic process| |camera-type eye morphogenesis| |ear morphogenesis| |terpenoid metabolic process| |cellular hormone metabolic process| |isoprenoid metabolic process| |morphogenesis of embryonic epithelium| |eye morphogenesis| |protein tetramerization| |monocarboxylic acid biosynthetic process| |inner ear development| |locomotory behavior| |respiratory system development| |hormone metabolic process| |ear development| |sensory organ morphogenesis| |telencephalon development| |embryonic organ morphogenesis| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |camera-type eye development| |alcohol metabolic process| |protein homooligomerization| |eye development| |visual system development| |sensory system development| |forebrain development| |gland development| |morphogenesis of an epithelium| |embryonic organ development| |organic hydroxy compound metabolic process| |protein complex oligomerization| |monocarboxylic acid metabolic process| |regulation of hormone levels| |sensory organ development| |tissue morphogenesis| |embryonic morphogenesis| |behavior| |lipid biosynthetic process| |small molecule biosynthetic process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |brain development| |head development| |protein homodimerization activity| |anatomical structure formation involved in morphogenesis| |carboxylic acid metabolic process| |animal organ morphogenesis| |cellular lipid metabolic process| |oxidation-reduction process| |embryo development| |central nervous system development| |oxoacid metabolic process| |organic acid metabolic process| |epithelium development| |lipid metabolic process| |nervous system process| |regulation of apoptotic process| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of cell death| |small molecule metabolic process| |tissue development| |protein-containing complex subunit organization| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.91| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|1.72| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.81| |[[:results:exp453|B02 10μM R08 exp453]]|2.22| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8214 * **Expression level (log2 read counts)**: 0.55 {{:chemogenomics:nalm6 dist.png?nolink |}}